Early Increases in Breast Tumor Xenograft Water Mobility in Response to Paclitaxel Therapy Detected by Non-Invasive Diffusion Magnetic Resonance Imaging

Neoplasia

Volumn 1, Issue 2, 1999, Pages 113-117

  Galons, Jean Philippe ^a,c   Altbach, Maria I ^a   Paine Murrieta, Gillian D ^b   Taylor, Charles W ^b   Gillies, Robert J ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; PACLITAXEL; WATER;

ANIMAL; ARTICLE; BREAST TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; DIFFUSION; DRUG RESISTANCE; EXPERIMENTAL NEOPLASM; HUMAN; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DIFFUSION; DRUG RESISTANCE, NEOPLASM; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; P-GLYCOPROTEIN; PACLITAXEL; TIME FACTORS; TUMOR CELLS, CULTURED; WATER;

EID: 0033140111     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900009     Document Type: Article

References (32)

1. Clemons M, Leahy M, Valle J, Jayson G, Ranson M, and Howell A (1997). Review of recent trials of chemotherapy for advanced breast cancer: The taxanes. Eur J Cancer 33, 2183-2193.
2. Chenevert TL, and Ross BD (1995). Diffusion, T1 and T2 as chemotherapeutic response predictors of experimental brain tumors. Proc Int Soc Magn Reson Med 2, p. 924.
3. Chenevert TL, McKeever PE, and Ross BD (1997). Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3, 1457-1466.
4. Zhao M, Pipe JG, Bonnett J, and Evelhoch JL (1996). Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 73, 61-64.
5. Zhao M, and Evelhoch JL (1996). Detection of response to 5-fluorouracil by diffusion-weighted 1H NMR spectroscopy in murine tumors In vivo. Proc Int Soc Magn Reson Med 2, p. 1118.
6. Rowinsky EK (1997). Paclitaxel pharmacology and other tumor types. Semin Oncol 24 [suppl 19], S19-1-S19-12.
7. van Ark-Otte J, Samelis G, Rubio G, Lopez Saez JB, Pinedo HM, and Giaccone G (1998). Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes. Oncol Rep 5, 249-255.
8. Mechetner E, Kyshtoobayeva A, Zonis S, Kim H, Stroup R, Garcia R, Parker RJ, and Fruehauf JP (1998). Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to paclitaxel and doxorubicin. Clin Cancer Res 4, 389-398.
9. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, Asgari H, and Norman D (1990). Diffusion-weighted MR imaging of acute stroke: Correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR: Am J Neuroradiol 11, 423-429.
10. Moseley ME, Cohen Y, Mintorovitch J, Chileuitt L, Shimizu H, Kucharczyk J, Wendland MF, and Weinstein PR (1990). Early detection of regional cerebral ischemia in cats: Comparison of diffusion-and T2-weighted MRI and spectroscopy. Magn Reson Med 14, 330-346.
11. Fischer M, Bockhorst K, Hoehn-Berlage M, Schmitz B, and Hossmann KA (1995). Imaging of the apparent diffusion coefficient for the evaluation of cerebral metabolic recovery after cardiac arrest. Magn Reson Imaging 13, 781-790.
12. Latour LL, Svoboda K, Mitra P, and Sotak CH (1994). Time-dependent diffusion of water in a biological model system. Pros Natl Acad Sci USA 91, 1229-1233.
13. Szafer A, Zhong J, and Gore JC (1995). Theoretical model for water diffusion in tissues. Magn Reson Med 33, 697-712.
14. van Gelderen P, de Vleeschouwer MH, DesPres D, Pekar J, van Zijl PC, and Moonen CT (1994). Water diffusion and acute stroke. Magn Reson Med 31, 154-163.
15. Warach S, Gaa J, Siewert B, Wielopolski P, and Edelman RR (1995). Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 37, 231-241.
16. Galons JP, Trouard T, Gmitro AF, and Lien YH (1996). Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging. J Clin Invest 98, 750-755.
17. Ross BD, Chenevert TL, Kim B, and Ben-Yoseph O (1994). Magnetic Resonance Imaging and Spectroscopy: Application to Experimental Neuro-Oncology. Q Magn Reson Biol Med 1, 85-102.
18. Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH, Roe DJ, and Trent JM (1991). Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer 63, 923-929.
19. Paine-Murrieta GD, Taylor CW, Curtis RA, Lopez MH, Dorr RT, Johnson CS, Funk CY, Thompson F, and Hersh EM (1997). Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol 40, 209-214.
20. Taetle R, Rosen F, Abramson I, Venditti J, and Howell S (1987). Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. Cancer Treat Rep 71, 297-304.
21. Altbach MI, Mattingly MA, Brown MF, and Gmitro AF (1991) Magnetic resonance imaging of lipid deposits in human atheroma via a stimulated-echo diffusion-weighted technique. Magn Reson Med 20, 319-324.
22. Basser PJ, and Pierpaoli C (1996). Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 111, 209-219.
23. Gan Y, Wientjes MG, Lu J, and Au JL (1998). Cytostatic and apoptotic effects of paclitaxel in human breast tumors. Cancer Chemother & Pharmacol 42, 177-182.
24. Ling YH, Yang Y, Tornos C, Singh B, and Perez-Soler R (1998). Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells. Cancer Res 58, 3633-3640.
25. Millenbaugh NJ, Gan Y, and Au JL (1998). Cytostatic and apoptotic effects of paclitaxel in human ovarian tumors. Pharm Res 15, 122-127.
26. Au JL, Li D, Gan Y, Gao X, Johnson AL, Johnston J, Millenbaugh NJ, Jang SH, Kuh HJ, Chen CT, and Wientjes MG (1998). Pharmacodynamics of immediate and delayed effects of paclitaxel: Role of slow apoptosis and intracellular drug retention. Cancer Res 58, 2141-2148.
27. Benson RS, Heer S, Dive C, and Watson AJ (1996). Characterisation of cell volume loss in CEM-C7A cells during dexamethasone-induced apoptosis. Am J Physiol 270(4pt1), C1190-C1230.
28. 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: Identification of apoptotic response. Cancer Res 58, 3791-3799.
29. Simon SM, and Schindler M (1994). Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 91, 3497-3504.
30. Nielsen D, and Skovsgaard T (1992). P-glycoprotein as multidrug transporter: A critical review of current multidrug resistant cell lines. Biochim Biophys Acta 1139, 169-183.
31. Klauber N, Parangi S, Flynn E, Hamel E, and D'Amato RJ (1997). Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and paclitaxel. Cancer Res 57, 81-86.
32. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, and Taraboletti G (1996). The microtubule-affecting drug paclitaxel has antigiogenic activity. Clin Cancer Res 2, 1843-1849.